These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Robust growth hormone (GH) secretion in aged female rats co-administered GH-releasing hexapeptide (GHRP-6) and GH-releasing hormone (GHRH). Walker RF; Yang SW; Bercu BB Life Sci; 1991; 49(20):1499-504. PubMed ID: 1943453 [TBL] [Abstract][Full Text] [Related]
23. Galanin counteracts the inhibitory effects of glucocorticoids on growth hormone secretion in the rat. Giustina A; Voltz DM; Teik J; Wehrenberg WB Metabolism; 1995 Feb; 44(2):224-7. PubMed ID: 7532779 [TBL] [Abstract][Full Text] [Related]
24. Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone. Robinson BM; Friberg RD; Bowers CY; Barkan AL J Clin Endocrinol Metab; 1992 Oct; 75(4):1121-4. PubMed ID: 1400881 [TBL] [Abstract][Full Text] [Related]
25. Effects of hypothyroidism, tri-iodothyronine and glucocorticoids on growth hormone responses to growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2. Edwards CA; Dieguez C; Scanlon MF J Endocrinol; 1989 Apr; 121(1):31-6. PubMed ID: 2497223 [TBL] [Abstract][Full Text] [Related]
26. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection. Pombo M; Barreiro J; Peñalva A; Peino R; Dieguez C; Casanueva FF J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423 [TBL] [Abstract][Full Text] [Related]
27. Differential regulation of GHRH-receptor and GHS-receptor expression by long-term in vitro treatment of ovine pituitary cells with GHRP-2 and GHRH. Roh SG; Doconto M; Feng DD; Chen C Endocrine; 2006 Aug; 30(1):55-62. PubMed ID: 17185792 [TBL] [Abstract][Full Text] [Related]
28. GH-releasing peptide-6 overcomes refractoriness of somatotropes to GHRH after feeding. McMahon CD; Chapin LT; Radcliff RP; Lookingland KJ; Tucker HA J Endocrinol; 2001 Jul; 170(1):235-41. PubMed ID: 11431156 [TBL] [Abstract][Full Text] [Related]
29. Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6. Popovic V; Damjanovic S; Micic D; Petakov M; Dieguez C; Casanueva FF J Clin Endocrinol Metab; 1994 Aug; 79(2):456-60. PubMed ID: 8045963 [TBL] [Abstract][Full Text] [Related]
30. In vivo effects of the GH-releasing heptapeptide GHRP-1 in lambs. Charrier J; Fraysse A; Guilhermet R; Serra-Pujol R; Formal M; Bowers CY Reprod Nutr Dev; 1998; 38(3):245-54. PubMed ID: 9698275 [TBL] [Abstract][Full Text] [Related]
31. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism. Borges MH; DiNinno FB; Lengyel AM Clin Endocrinol (Oxf); 1997 Jun; 46(6):713-8. PubMed ID: 9274702 [TBL] [Abstract][Full Text] [Related]
32. Desensitization studies using perifused rat pituitary cells show that growth hormone-releasing hormone and His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 stimulate growth hormone release through distinct receptor sites. Blake AD; Smith RG J Endocrinol; 1991 Apr; 129(1):11-9. PubMed ID: 1674284 [TBL] [Abstract][Full Text] [Related]
33. Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat. Locatelli V; Grilli R; Torsello A; Cella SG; Wehrenberg WB; Müller EE Pediatr Res; 1994 Aug; 36(2):169-74. PubMed ID: 7970930 [TBL] [Abstract][Full Text] [Related]
34. Oral activity of the growth hormone releasing peptide His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in rats, dogs and monkeys. Walker RF; Codd EE; Barone FC; Nelson AH; Goodwin T; Campbell SA Life Sci; 1990; 47(1):29-36. PubMed ID: 2117689 [TBL] [Abstract][Full Text] [Related]
35. Ipamorelin, the first selective growth hormone secretagogue. Raun K; Hansen BS; Johansen NL; Thøgersen H; Madsen K; Ankersen M; Andersen PH Eur J Endocrinol; 1998 Nov; 139(5):552-61. PubMed ID: 9849822 [TBL] [Abstract][Full Text] [Related]
36. Growth hormone response to GHRH, GHRP-6 and GHRH + GHRP-6 in patients with polycystic ovary syndrome. Micić D; Kendereski A; Popović V; Sumarac M; Zorić S; Macut D; Dieguez C; Casanueva F Clin Endocrinol (Oxf); 1996 Oct; 45(4):385-90. PubMed ID: 8959075 [TBL] [Abstract][Full Text] [Related]
37. Growth hormone responses to GH-releasing peptide (GHRP-6) in hypothyroidism. Pimentel-Filho FR; Ramos-Dias JC; Ninno FB; Façanha CF; Liberman B; Lengyel AM Clin Endocrinol (Oxf); 1997 Mar; 46(3):295-300. PubMed ID: 9156038 [TBL] [Abstract][Full Text] [Related]
38. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313 [TBL] [Abstract][Full Text] [Related]
39. Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging. Ghigo E; Arvat E; Rizzi G; Goffi S; Grottoli S; Mucci M; Boghen MF; Camanni F Eur J Endocrinol; 1994 Nov; 131(5):499-503. PubMed ID: 7952160 [TBL] [Abstract][Full Text] [Related]
40. Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration. Ghigo E; Arvat E; Rizzi G; Bellone J; Nicolosi M; Boffano GM; Mucci M; Boghen MF; Camanni F J Endocrinol Invest; 1994 Mar; 17(3):157-62. PubMed ID: 8051337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]